Actively Recruiting
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
Led by Cedars-Sinai Medical Center · Updated on 2019-02-11
2000
Participants Needed
1
Research Sites
626 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
CONDITIONS
Official Title
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Severe aortic stenosis with bicuspid valve anatomy
- New York Heart Association (NYHA) class 2 or higher and/or syncope and/or angina
- Patient assessed by the Heart Team as appropriate for transcatheter aortic valve replacement (TAVR)
You will not qualify if you...
- Age less than 18 years
- Patients without symptoms related to aortic valve disease
- Pure aortic valve regurgitation without stenosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
Actively Recruiting
Research Team
S
Sung-Han Yoon, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here